Press Releases

DZIF news and press releases at a glance

Focussing on Ebola virus
© Philipps-Universität Marburg

Ebola: Clinical trials for a safe vaccine

A clinical phase I trial for a potential vaccine against the dreaded Ebola virus can now begin. The candidate vaccine has already successfully been tested in different animal models. The trial is

Ebola-Viren im Fokus
© Philipps-Universität Marburg

EBOKON: Strengthening Ebola Research

The German Center for Infection Research (DZIF) has initiated a consortium to strengthen Ebola research and close the knowledge gaps as quickly as possible in the fight against the epidemic. This

Tuberculosis bacteria
© CDC/James Archer

Tuberculosis: Better diagnosis in children

Rapid and reliable diagnosis of paediatric tuberculosis is still an ongoing problem. The most important prerequisite for successful treatment of active tuberculosis is its early diagnosis. A team of

Dirk Busch und sein Team
© TUM/Astrid Eckert

Individual central memory T cells are "multipotent"

Researchers in Germany and the U.S. have proven for the first time that specific individual cells of the immune system, termed central memory T cells, have all the essential characteristics of adult

Marburger Sicherheitslabor
© DZIF/scienceRELATIONS

Coronaviruses: Getting to a vaccine as fast as possible

At the German Center for Infection Research (DZIF), researchers are working intensively to make available a vaccine against the dreaded MERS coronavirus as soon as possible. A candidate vaccine has

Universitätsklinikum Freiburg
© Universitätsklinikum Freiburg

Less is more: Targeted reduction of antibiotic use in hospitals is possible

Antimicrobial resistance is a growing concern: Hospitals are increasingly being confronted with bacterial infections for which there is no cure. The frequent use of broad spectrum antibiotics, which

Malaria: New Vaccination Method goes into Clinical Trials

Malaria is still not under control despite numerous attempts. On the contrary: Resistance against the commonly used drugs is further impeding the fight against this dangerous infectious disease. This

Hepatitis B: New treatment possibilities

Viruses such as hepatitis B virus (HBV) can persist by depositing their genetic information in the cell nucleus. An international team of scientists headed by Prof. Ulrike Protzer and Prof. Mathias

Managing Board of the new DZIF Transplant Cohort (from left to right): Prof. Dr. Dirk Busch (Munich), Prof. Dr. Claudia Sommerer (Heidelberg), Prof. Dr. Wolfgang Bethge (Tübingen), Prof. Dr. Arnold Ganser (Hannover), Prof. Dr. Lutz Renders (Munich), Prof. Dr. Klaus Kuhn (Munich), Prof. Dr. Thomas Schulz (Hanover)
© DZIF

DZIF Transplant Cohort starts its work

On its first General Assembly, which took place in Frankfurt/Main today, the Transplant Cohort was founded as a part of the German Centre for Infection Research (DZIF). With this, the newly founded

Clostridium difficile
© CDC/Lois S. Wiggs

Microbiome and infections

Researchers from the German Center for Infection Research (DZIF) in Hannover, Munich and Tübingen have now signed a cooperation agreement for the new Center for Gastrointestinal Microbiome Research

Jetzt für den DZIF-Presseverteiler anmelden

Erhalten Sie die Pressemitteilungen des DZIF direkt in Ihren Posteingang.